ArticleClinicoEconomics and outcomes research : CEOR2023

Weight and BMI Changes Following Initiation of Emtricitabine/Tenofovir Alafenamide Co-Formulated with Darunavir or Co-Administered with Dolutegravir in Overweight or Obese, ART-Naïve People Living with HIV-1.

Prina Donga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.